Abstract:Objective To detect the serum Chemerin levels in patients with obesity and newly diagnosed type 2 diabetes mellitus (T2DM) and explore the relationship of serum Chemerin to body fat parameters, glucose and lipid metabohsm, and insulin resistance index (IR). Methods 76 newly diagnosed T2DM patients and 76 subjects with normal glucose regulation (NGR), with the body mass index (BMI) <25 kg/m2 (NW) or ≥25 kg/m2 (OW/OB), 38 in each subgroups each, underwent body measurement including body weight, height, waist circumference, and hip circumference, and waist hip ratio (WHR) and calculation of body mass index (BMI) were calculated. Peripheral blood samples were collected from them to detect the blood lipids, glucose, hemoglobin A1C, fasting insulin (FINS), and fasting C peptide. Homeostasis model assessment insulin resistance index (HOMA-IR) was calculated. ELISA was used to detect the Chemerin level, body mass index (BMI) and waist hip ratio (WHR) were evaluated and insulin sensitivity was assessed by HOMA-IR. Results The serum Chemerin level of the females was ( 109 ± 28) μg/L, significantly higher than that of the males [ (98 ± 23 ) μ/L, P < 0. 05 ]. After adjustment of gender and age, the serum Chemerin level of the OW/OB group, including NGR-OW/ OB and T2DM-OW/OB subgroups, was (113 ± 27) μg/L, significantly higher than that of the NW group [ (94±25) μg/ L, P <0. 01 ], that of the NGR-OW/OB subgroup being the highest. Partial correlation analyses showed that the serum Chemerin was positively correlated with waist circumference, WHR, fasting serum C peptide, HOMA-IR, TG, ALT, γ-GT, and uric acid (r =0.460-0. 182, all P<0.05) and negatively correlated with high density lipoprotein-cholesterol ( r = - 0. 251, P < 0. 01 ). Stepwise regression analysis showed that fasting serum C peptide and TG were the independent variables of Chemerin (β = 0. 328, 0. 280,P < 0. 05 ). Conclusion Serum Chemerin levels are much higher in females and obese subjects are much higher than in men and subjects with normal weight. Serum Chemerin is correlated with insulin level, body fat disposition and lipid metabolism which suggesting that it may play a role in the pathophysiology of obesity and metabolic syndrome.

Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.

Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes

Independent Association of Circulating Level of Chemerin With Functional and Early Morphological Vascular Changes in Newly Diagnosed Type 2 Diabetic Patients

Chemerin/CMKLR1 Axis Promotes the Progression of Proliferative Diabetic Retinopathy

Is Chemerin Associated with Gestational Diabetes Mellitus? an Evidence-Based Clinical Research from Chinese Women

Elevation of Serum Apelin-13 Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Patients.

Comprehensive Analysis of Vitreous Humor Chemokines in Type 2 Diabetic Patients with and Without Diabetic Retinopathy

Chemerin Levels in Individuals with Type 2 Diabetes and a Normal Weight versus Individuals with Type 2 Diabetes and Obesity: An Observational, Cross-Sectional Study

Relationship of serum Chemerin to obesity and type 2 diabetes mellitus

Relationship Between Retinol and Risk of Diabetic Retinopathy: a Case-Control Study.

Association of serum chemerin level with early renal insufficiency in patients with type 2 diabetes

Chemerin Promotes the Development of Diabetic Retinopathy

Impacts of Chemerin Levels and Antioxidant Capacity on the Severity of Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes and Prediabetes

Association of diabetic retinopathy with serum periostin and vascular endothelial growth factor

Serum Cholinesterase is Associated with Incident Diabetic Retinopathy: the Shanghai Nicheng Cohort Study

Correlation of MMP-2, TIMP-1, β2-MG and hs-CRP with the progression of retinopathy in patients with type 2 diabetes

Relationship between Serum Chemerin and Carotid Plague in Patients with Type 2 Diabetes Mellitus

C-reactive Protein and Type 2 Diabetic Retinopathy

Serum Microrna-221 As a Biomarker for Diabetic Retinopathy in Patients Associated with Type 2 Diabetes

The Relationship Between Serum Levels of Inflammatory Factors,Adiponectin and Atherosclerosis in the Patients with Type 2 Diabetes Mellitus

Elevated Plasma and Vitreous Levels of Leucine‐rich‐α2‐glycoprotein Are Associated with Diabetic Retinopathy Progression